arrow_back Back to App

Health Officials Ethics Reform: Restrictions on Industry Jobs and Drug Patents.

This bill imposes strict limitations on former high-ranking officials from key health agencies (NIH, FDA, CDC) to prevent conflicts of interest. The goal is to increase public trust in regulatory decisions regarding drugs and medical devices. These officials face an 8-year ban on serving on pharmaceutical company boards and are prohibited from profiting from products related to grants they approved.
Key points
Imposes an 8-year ban on top former NIH, FDA, and CDC officials from serving on the boards of companies researching or manufacturing drugs and devices.
Prohibits former employees from profiting from drugs or devices if they were directly involved in approving related grant applications (subject to penalties and imprisonment).
Requires top officials and their spouses to disclose any ownership or financial interest in patents for drugs, biological products, or devices.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_4232
Sponsor: Sen. Vance, J. D. [R-OH]
Process start date: 2024-05-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

FAUCI Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_4232.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-05-01.

What are the main provisions?

Key points include:

  • Imposes an 8-year ban on top former NIH, FDA, and CDC officials from serving on the boards of companies researching or manufacturing drugs and devices.
  • Prohibits former employees from profiting from drugs or devices if they were directly involved in approving related grant applications (subject to penalties and imprisonment).
  • Requires top officials and their spouses to disclose any ownership or financial interest in patents for drugs, biological products, or devices.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Vance, J. D. [R-OH].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Courts and Law Economy